Get alerts when PRLB reports next quarter
Set up alerts — freeProto Labs shares fell 14.6% after earnings, despite 14% revenue growth, as the transcript provides no specific forward outlook to explain how the recent momentum will continue. The market reaction suggests investors were disappointed by the outlook or by factors not addressed in the available transcript, so the growth and margin claims do not resolve the concern.
See PRLB alongside your other holdings
Add to your portfolio — freeTrack Proto Labs, Inc. in your portfolio with real-time analytics, dividend tracking, and more.
View PRLB Analysis